Washington–based Cardiac Insight has gained FDA marketing clearance for its Cardea Solo wearable electrocardiogram sensor.
The Cardea Solo is used to assist in the diagnosis of a variety of arrhythmias by recording ECG data and patient symptoms.
The device weighs about 25 grams and is lead-less, water-resistant and single-use disposable. It is designed to encourage better patient compliance for recording of data. — Cynthia Jessup